NP / PA
Munoz Pediatrics (Dba) Weekare Pediatrics
Munoz Pediatrics (Dba) Weekare Pediatrics was paid $17.49M by Medicaid between Jan 2018 and Dec 2024, across 81 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoMUNOZ PEDIATRICS (DBA) WEEKARE PEDIATRICS
HUMBLE, TX 77338
HUMBLE, TX 77338
33aNPI1093878506assigned 12/18/2006
33bProvider typePediatric Nurse Practitioner
28Total paid$17.49M
24GClaims738,217
24DCodes billed81
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatric Nurse Practitioner providers in Texas
Rank by total paid#1 of 51
Median peer was paid$10K
This provider vs. median1,788×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,156 | $104K | |
| 2019 | 4,925 | $115K | |
| 2020 | 44,122 | $839K | |
| 2021 | 191,071 | $3.93M | |
| 2022 | 181,306 | $4.54M | |
| 2023 | 176,967 | $4.35M | |
| 2024incomplete | 136,670 | $3.60M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 104,385 | 96,390 | $5.11M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.9% | 22,730 | 22,160 | $1.74M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 9.7% | 22,493 | 21,446 | $1.69M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.4% | 19,620 | 18,850 | $1.47M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.2% | 17,435 | 17,134 | $1.43M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.5% | 107,569 | 41,608 | $1.13M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.0% | 10,017 | 9,789 | $881K |
| 87428 | 4.1% | 14,183 | 13,743 | $710K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.0% | 4,162 | 4,002 | $349K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 24,309 | 23,323 | $327K |
| 99381 | 1.8% | 3,751 | 3,668 | $307K | |
| 99000 | 1.7% | 30,856 | 29,315 | $296K |
69 more codes
| 99213 | Doctor's office visit, returning patient (routine) | 1.6% | 7,827 | $280K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.5% | 6,495 | $263K |
| 99205 | Prolong outpt/office vis | 1.5% | 2,332 | $255K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.2% | 26,037 | $206K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,049 | $150K |
| 90461 | <1% | 28,293 | $144K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 8,413 | $112K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,946 | $86K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 828 | $66K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 5,967 | $55K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,560 | $50K |
| 87807 | <1% | 4,458 | $47K | |
| 69210 | <1% | 1,251 | $38K | |
| 99383 | <1% | 378 | $34K | |
| 99429 | <1% | 1,017 | $31K | |
| 17250 | <1% | 454 | $29K | |
| 96160 | <1% | 12,176 | $26K | |
| 94760 | <1% | 25,374 | $22K | |
| 92551 | <1% | 36,596 | $19K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 1,812 | $17K |
| 99072 | <1% | 30,044 | $16K | |
| 99050 | <1% | 1,189 | $16K | |
| 92587 | <1% | 1,550 | $15K | |
| 97169 | <1% | 1,054 | $13K | |
| 92567 | <1% | 994 | $11K | |
| 99384 | <1% | 94 | $9K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 164 | $9K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 631 | $8K |
| 99382 | <1% | 82 | $7K | |
| 81002 | <1% | 2,455 | $7K | |
| 69209 | <1% | 390 | $3K | |
| 90677 | <1% | 3,922 | $1K | |
| 96380 | <1% | 26 | $480.08 | |
| 86580 | <1% | 27 | $203.91 | |
| 99051 | <1% | 12 | $162.24 | |
| 90619 | <1% | 1,465 | $161.62 | |
| 90661 | <1% | 1,323 | $54.85 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 283 | $29.49 |
| 90674 | <1% | 2,119 | $20.12 | |
| 99173 | <1% | 15,448 | $14.53 | |
| 90697 | <1% | 7,881 | $11.57 | |
| 36416 | <1% | 1,339 | $7.35 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 76 | $4.56 |
| 90686 | <1% | 7,611 | $3.76 | |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | <1% | 1,190 | $2.55 |
| 90651 | <1% | 4,130 | $0.69 | |
| 97802 | <1% | 360 | $0.58 | |
| 90620 | <1% | 749 | $0.21 | |
| 90734 | <1% | 1,635 | $0.06 | |
| 90670 | <1% | 12,689 | $0.02 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 31 | $0.01 |
| 90633 | 0% | 8,461 | $0.00 | |
| 90707 | 0% | 7,716 | $0.00 | |
| 90715 | 0% | 1,146 | $0.00 | |
| 90700 | 0% | 1,945 | $0.00 | |
| 1033F | 0% | 3,238 | $0.00 | |
| 99177 | 0% | 22,297 | $0.00 | |
| 90681 | 0% | 2,075 | $0.00 | |
| 94664 | 0% | 268 | $0.00 | |
| 1159F | 0% | 21 | $0.00 | |
| 90647 | 0% | 5,772 | $0.00 | |
| 90716 | 0% | 7,918 | $0.00 | |
| 90680 | 0% | 7,628 | $0.00 | |
| 90723 | 0% | 4,886 | $0.00 | |
| 90696 | 0% | 2,025 | $0.00 | |
| 96161 | 0% | 31 | $0.00 | |
| 3008F | 0% | 21 | $0.00 | |
| 90381 | 0% | 12 | $0.00 | |
| 1125F | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMUNOZ, JESUS (NEONATOLOGIST/OWNER CEO)